 Equities research analysts expect Five Prime Therapeutics Inc NASDAQ:FPRX to report sales of 5.90 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Five Prime Therapeutics earnings. The lowest sales estimate is 3.07 million and the highest is 10.00 million. Five Prime Therapeutics posted sales of 5.35 ... 